This page is part of the Potential Drug-Drug Interaction (PDDI) Clinical Decision Support (CDS) (FHIR IG) (v0.2.0: STU 1 Ballot 2) based on FHIR R4. . For a full list of available versions, see the Directory of published versions
<ValueSet xmlns="http://hl7.org/fhir"> <id value="valueset-cyclosporine-exclude"/> <text> <status value="generated"/> <div xmlns="http://www.w3.org/1999/xhtml"><ul><li>Include these codes as defined in <a href="http://www.nlm.nih.gov/research/umls/rxnorm"><code>http://www.nlm.nih.gov/research/umls/rxnorm</code></a> version <code>02-Jul-2018</code><table class="none"><tr><td style="white-space:nowrap"><b>Code</b></td><td><b>Display</b></td></tr><tr><td>1093178</td><td>Cyclosporine 0.002 MG/MG Ophthalmic Ointment [Optimmune]</td><td/></tr><tr><td>402092</td><td>Cyclosporine 0.5 MG/ML Ophthalmic Suspension [Restasis]</td><td/></tr><tr><td>1093177</td><td>Cyclosporine Ophthalmic Ointment [Optimmune]</td><td/></tr><tr><td>402330</td><td>Cyclosporine Ophthalmic Suspension [Restasis]</td><td/></tr><tr><td>1093174</td><td>Cyclosporine 0.002 MG/MG Ophthalmic Ointment</td><td/></tr><tr><td>351291</td><td>Cyclosporine 0.5 MG/ML Ophthalmic Suspension</td><td/></tr><tr><td>1093173</td><td>Cyclosporine Ophthalmic Ointment</td><td/></tr><tr><td>378766</td><td>Cyclosporine Ophthalmic Suspension</td><td/></tr><tr><td>1156187</td><td>Cyclosporine Ophthalmic Product</td><td/></tr><tr><td>1182342</td><td>Optimmune Ophthalmic Product</td><td/></tr><tr><td>1182527</td><td>Restasis Ophthalmic Product</td><td/></tr></table></li></ul></div> </text> <url value="http://hl7.org/fhir/uv/pddi/ValueSet/valueset-cyclosporine-exclude"/> <version value="0.2.0"/> <name value="Valueset_cyclosporine_exclude"/> <title value="Exclude cyclosporine Medications Value Set"/> <status value="draft"/> <date value="2018-07-02"/> <publisher value="PDDI CDS"/> <contact> <name value="Richard Boyce"/> </contact> <description value="ValueSet containing drug identifiers to exclude. Criteria is explicitly stating ophthalmic formulations."/> <jurisdiction> <coding> <system value="http://unstats.un.org/unsd/methods/m49/m49.htm"/> <code value="001"/> <display value="World"/> </coding> </jurisdiction> <purpose value="To refine valueset for Digoxin + Cyclosporine PDDI-CDS"/> <copyright value="Attribution CC BY"/> <compose> <include> <system value="http://www.nlm.nih.gov/research/umls/rxnorm"/> <version value="02-Jul-2018"/> <concept> <code value="1093178"/> <display value="Cyclosporine 0.002 MG/MG Ophthalmic Ointment [Optimmune]"/> </concept> <concept> <code value="402092"/> <display value="Cyclosporine 0.5 MG/ML Ophthalmic Suspension [Restasis]"/> </concept> <concept> <code value="1093177"/> <display value="Cyclosporine Ophthalmic Ointment [Optimmune]"/> </concept> <concept> <code value="402330"/> <display value="Cyclosporine Ophthalmic Suspension [Restasis]"/> </concept> <concept> <code value="1093174"/> <display value="Cyclosporine 0.002 MG/MG Ophthalmic Ointment"/> </concept> <concept> <code value="351291"/> <display value="Cyclosporine 0.5 MG/ML Ophthalmic Suspension"/> </concept> <concept> <code value="1093173"/> <display value="Cyclosporine Ophthalmic Ointment"/> </concept> <concept> <code value="378766"/> <display value="Cyclosporine Ophthalmic Suspension"/> </concept> <concept> <code value="1156187"/> <display value="Cyclosporine Ophthalmic Product"/> </concept> <concept> <code value="1182342"/> <display value="Optimmune Ophthalmic Product"/> </concept> <concept> <code value="1182527"/> <display value="Restasis Ophthalmic Product"/> </concept> </include> </compose> </ValueSet>